Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck KGaA reports interim analysis from Erbitux adjuvant study

May 10, 2012

Seattle Genetics molecule inhibits fucosylation in vitro and in vivo

May 10, 2012

New Kyowa Hakko Kirin product demonstrates anticancer activity

May 10, 2012

Novel anticancer compounds synthesized at Nerviano Medical Sciences

May 10, 2012

Rexahn Pharmaceuticals submits ovarian cancer study protocol to FDA

May 9, 2012

GTx gives update on Capesaris IND

May 9, 2012

FDA provides update on Revlimid

May 9, 2012

Roche submits application for anticancer drug in Australia

May 9, 2012

Genta begins phase II trial of tesetaxel in gastric cancer

May 9, 2012

Generon begins phase II trial of F-627

May 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...